Published in Eur J Clin Invest on August 01, 1974
A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med (1975) 2.59
High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction. J Exp Med (1978) 1.91
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Biochemistry of bile secretion. Biochem J (1987) 1.41
Transcytosis and paracellular movements of horseradish peroxidase across liver parenchymal tissue from blood to bile. Effects of alpha-naphthylisothiocyanate and colchicine. Biochem J (1985) 1.36
A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes. J Clin Invest (1995) 1.33
Sources of proteins in human bile. Gut (1985) 1.21
Biliary protein output by isolated perfused rat livers. Effects of bile salts. Biochem J (1983) 1.20
The role of the Brambell receptor (FcRB) in liver: protection of endocytosed immunoglobulin G (IgG) from catabolism in hepatocytes rather than transport of IgG to bile. Immunology (2000) 1.09
1-Naphthylisothiocyanate-induced permeability of hepatic tight junctions to proteins. Biochem J (1986) 1.07
Studies on the mechanisms of biliary excretion of circulating glycoproteins. The carcinoembryonic antigen. Biochem J (1980) 1.07
Demonstration of IgA and secretory component in human hepatocytes. Gut (1980) 1.05
Abnormal secretion of proteins into bile from colchicine-treated isolated perfused rat livers. Biochem J (1983) 0.99
Effects of colchicine and vinblastine on output of proteins into bile. Biochem J (1982) 0.95
Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics. Front Immunol (2015) 0.84
Effects of percutaneous transhepatic biliary drainage on blood-bile permeability and selective IgA transport in patients with biliary obstructions. Ann Surg (1990) 0.77
Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry (1965) 96.68
Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J Exp Med (1969) 5.12
The distribution of immunoglobulin-containing cells along the human gastrointestinal tract. Gastroenterology (1966) 3.98
Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin. J Exp Med (1969) 3.79
Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J (1993) 3.75
Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (1991) 3.61
The normal microbial flora as a major stimulus for proliferation of plasma cells synthesizing IgA in the gut. The germ-free intestinal tract. Int Arch Allergy Appl Immunol (1968) 3.33
Association of lactoferrin with specific granules in rabbit heterophil leukocytes. J Exp Med (1970) 3.32
Cell damage-induced conformational changes of the pro-apoptotic protein Bak in vivo precede the onset of apoptosis. J Cell Biol (1999) 3.18
Metal-combining properties of human lactoferrin (red milk protein). 1. The involvement of bicarbonate in the reaction. Eur J Biochem (1968) 2.80
The involvement of lactoferrin in the hyposideremia of acute inflammation. J Exp Med (1974) 2.75
A mechanism for the induction of immunological tolerance by antigen feeding: antigen-antibody complexes. J Exp Med (1975) 2.59
Rapid disappearance from serum of intravenously injected rat myeloma IgA and its secretion into bile. Eur J Immunol (1978) 2.48
Molecular weight, single-chain structure and amino acid composition of human lactoferrin. Eur J Biochem (1971) 2.47
Rat bile as a convenient source of secretory IgA and free secretory component. Eur J Immunol (1977) 2.47
Immunohistochemical observations on lymphoid tissues from conventional and germ-free mice. Lab Invest (1970) 2.45
Protein A reactivity of various mammalian immunoglobulins. Scand J Immunol (1978) 2.43
IgA subclasses in various secretions and in serum. Immunology (1982) 2.43
Immunohistochemical localization and bacteriostatic properties of an iron-binding protein from bronchial mucus. Thorax (1966) 2.42
Glutaraldehyde-activated aminohexyl- derivative of Sepharose 4B as a new verstile immunoabsorbent. Immunochemistry (1975) 2.42
Transplantable immunoglobulin-secreting tumours in rats. IV. Sixty-three IgE-secreting immunocytoma tumours. Immunology (1974) 2.36
The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA. Proc Natl Acad Sci U S A (1991) 2.02
Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq. Clin Exp Immunol (1976) 2.00
Lack of gamma A-immunoglobulin in serum of patients with steatorrhoea. Gut (1966) 1.97
High levels of secretory IgA and free secretory component in the serum of rats with bile duct obstruction. J Exp Med (1978) 1.91
Mesenteric lymph as a major source of serum IgA in guinea pigs and rats. Eur J Immunol (1973) 1.90
Lung mucosal immunity: immunoglobulin-A revisited. Eur Respir J (2001) 1.87
Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A. J Clin Invest (1983) 1.86
Influence of repeated administration of antigen by the oral route on specific antibody-producing cells in the mouse spleen. Digestion (1973) 1.84
Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest (1982) 1.84
Lactoferrin in milk from different species. Comp Biochem Physiol B (1971) 1.82
'Fit-for-purpose' validation of SearchLight multiplex ELISAs of angiogenesis for clinical trial use. J Immunol Methods (2009) 1.81
Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci (1996) 1.80
Subclasses of human immunoglobulin a based on differences in the alpha polypeptide chains. Science (1966) 1.79
Origin and molecular size of immunoglobulin-A in the mesenteric lymph of the dog. Immunology (1970) 1.78
Biomarkers of angiogenesis and their role in the development of VEGF inhibitors. Br J Cancer (2009) 1.78
Epigenetic determinants of resistance to etoposide regulation of Bcl-X(L) and Bax by tumor microenvironmental factors. J Natl Cancer Inst (2000) 1.77
Interference of oral immunization with the intestinal absorption of heterologous albumin. Eur J Immunol (1974) 1.74
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun (1994) 1.68
Further studies on single radial immunodiffusion. II. The reversed system: diffusion of antibodies in antigen-containing gels. Immunochemistry (1969) 1.68
Transplantable immunoglobulin-secreting tumours in rats. I. General features of LOU-Ws1 strain rat immunocytomas and their monoclonal proteins. Int J Cancer (1972) 1.66
Studies on the proteins of human saliva. Biochim Biophys Acta (1965) 1.65
Selective IgA deficiency with steatorrhea. A new syndrome. Am J Med (1967) 1.63
Nature and origin of the proteins of bile. I. A comparative analysis of serum and bile proteins in man. Eur J Clin Invest (1974) 1.59
Influence of molecular size of IgA on its immunoassay by various techniques. II. Solid-phase radioimmunoassays. J Immunol Methods (1982) 1.59
bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res (1993) 1.59
Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif. Mol Microbiol (2000) 1.56
Relevance of biliary IgA antibodies in rat intestinal immunity. Scand J Immunol (1978) 1.53
Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Br J Cancer (2009) 1.50
A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer (2011) 1.50
Apoptosis and cancer chemotherapy. Trends Cell Biol (2001) 1.48
Secretion of immunoglobulins and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest (1984) 1.44
Oral immunization against cholera toxin with a live Yersinia enterocolitica carrier in mice. Gastroenterology (1992) 1.43
Biomarker method validation in anticancer drug development. Br J Pharmacol (2007) 1.41
Studies on the proteins of human bronchial secretions. Biochim Biophys Acta (1965) 1.39
Reduced epithelial expression of secretory component in small airways correlates with airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 1.39
Thirty cases of monoclonal immunoglobulin disorders other than myeloma or macroglobulinemia. A classification of diseases associated with the production of monoclonal-type immunoglobulins. Am J Med (1969) 1.38
Validation of pharmacodynamic assays to evaluate the clinical efficacy of an antisense compound (AEG 35156) targeted to the X-linked inhibitor of apoptosis protein XIAP. Br J Cancer (2005) 1.36
A possible homologue of mammalian IgA in chicken serum and secretions. Immunology (1972) 1.35
Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci (1990) 1.34
Optimisation of circulating biomarkers of cell death for routine clinical use. Ann Oncol (2008) 1.32
Damage-induced Bax N-terminal change, translocation to mitochondria and formation of Bax dimers/complexes occur regardless of cell fate. EMBO J (2001) 1.32
Hepatobiliary transport of plasma IgA in the mouse: contribution to clearance of intravascular IgA. Eur J Immunol (1985) 1.32
Altered patterns of secretion of monomeric IgA and IgA subclass 1 by intestinal mononuclear cells in inflammatory bowel disease. Gastroenterology (1986) 1.31
The metabolism of different immunoglobulin classes in irradiated mice. V. Contribution of the gut to serum IgA levels in normal and irradiated mice. Immunology (1971) 1.31
Proapoptotic Bid binds to monolysocardiolipin, a new molecular connection between mitochondrial membranes and cell death. Cell Death Differ (2003) 1.27
PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia. Oncogene (2008) 1.26
Immunoglobulin A and polymeric IgA rheumatoid factors in systemic sicca syndrome: partial characterization. J Immunol (1982) 1.25
Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol (1999) 1.24
Cellular damage signals promote sequential changes at the N-terminus and BH-1 domain of the pro-apoptotic protein Bak. Oncogene (2001) 1.23
Distribution of alpha-chain subclasses in normal and pathological IgA-globulins. Immunology (1968) 1.23
On the significance of the heterogeneity in molecular size of human serum gamma A-globulins. Immunochemistry (1965) 1.23
Immunoglobulin levels in cord-blood serum of negroes and Caucasians. Trop Geogr Med (1966) 1.23
Influence of molecular size of IgA on its immunoassay by various techniques--I. Direct and reversed single radial immunodiffusion. Mol Immunol (1982) 1.22
Stimulation of transcytosis of the polymeric immunoglobulin receptor by dimeric IgA. Proc Natl Acad Sci U S A (1994) 1.21
Immunoglobulin formation and function in different tissues. Curr Top Microbiol Immunol (1968) 1.20
Immunohistochemical localization of the iron-binding protein lactoferrin in human bronchial glands. Experientia (1965) 1.20
Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 1.20
Effects of cisplatin on the induction of apoptosis in proliferating hepatoma cells and nonproliferating immature thymocytes. Cancer Res (1993) 1.20
Qualification of M30 and M65 ELISAs as surrogate biomarkers of cell death: long term antigen stability in cancer patient plasma. Cancer Chemother Pharmacol (2007) 1.19
Electrophoretic morphology of gamma globulins in cerebrospinal fluid of multiple sclerosis and other diseases of the nervous system. Neurology (1970) 1.19
In vivo experiments involving secretory component in the rat hepatic transfer of polymeric IgA from blood into bile. Immunology (1981) 1.18
Activated c-SRC in ductal carcinoma in situ correlates with high tumour grade, high proliferation and HER2 positivity. Br J Cancer (2006) 1.18
Reactivating HIF prolyl hydroxylases under hypoxia results in metabolic catastrophe and cell death. Oncogene (2009) 1.17
Biological significance of exocrine gamma-A-immunoglobulin. Acta Med Scand Suppl (1966) 1.17